Please wait





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  The percentages reported in this Schedule 13G are based upon 31,911,164 Shares outstanding as of February 6, 2026 (according to the Issuer's 424B4 Prospectus as filed with the Securities and Exchange Commission on February 6, 2026).


SCHEDULE 13G




Comment for Type of Reporting Person:  The percentages reported in this Schedule 13G are based upon 31,911,164 Shares outstanding as of February 6, 2026 (according to the Issuer's 424B4 Prospectus as filed with the Securities and Exchange Commission on February 6, 2026).


SCHEDULE 13G




Comment for Type of Reporting Person:  The percentages reported in this Schedule 13G are based upon 31,911,164 Shares outstanding as of February 6, 2026 (according to the Issuer's 424B4 Prospectus as filed with the Securities and Exchange Commission on February 6, 2026).


SCHEDULE 13G




Comment for Type of Reporting Person:  The percentages reported in this Schedule 13G are based upon 31,911,164 Shares outstanding as of February 6, 2026 (according to the Issuer's 424B4 Prospectus as filed with the Securities and Exchange Commission on February 6, 2026).


SCHEDULE 13G



 
Sands Capital Life Sciences Pulse Fund III (DE), L.P.
 
Signature:/s/ Jonathan Goodman
Name/Title:Jonathan Goodman, General Counsel of the GP of the GP of Sands Capital Life Sciences Pulse Fund III (DE), L.P.
Date:02/13/2026
 
Sands Capital Life Sciences Pulse Fund III-Holdings, L.P.
 
Signature:/s/ Jonathan Goodman
Name/Title:Jonathan Goodman, General Counsel of the GP of the GP of Sands Capital Life Sciences Pulse Fund III-Holdings, L.P.
Date:02/13/2026
 
Sands Capital Alternatives, LLC
 
Signature:/s/ Jonathan Goodman
Name/Title:Jonathan Goodman, General Counsel
Date:02/13/2026
 
SANDS FRANK M.
 
Signature:/s/ Frank M. Sands
Name/Title:Frank M. Sands
Date:02/13/2026

Comments accompanying signature:  Sands Capital Life Sciences Pulse Fund III (DE), L.P. and Sands Capital Life Sciences Pulse Fund III-Holdings, L.P. signed by Sands Capital Life Sciences Pulse Fund III-GP, L.P., its general partner, by Sands Capital Life Sciences Pulse Fund III-GP, LLC, its general partner, by Jonathan Goodman, General Counsel.